TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33726499

Group type: EXPERIMENTAL
Intervention: pUDK‐HGF treatment (intramuscular injection on days 0, 14, and 28)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: pUDK‐HGF treatment
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 36069821

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (taxane and anthracycline-based) with investigational agents
Number of subjects: 933

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (taxane and anthracycline-based) without investigational agents
Number of subjects: 933
Study: 33982806

Group type: EXPERIMENTAL
Intervention: IFN-α-2b aerosol inhalation (5,000,000 U twice daily)
Number of subjects: 1401

Group type: COMPARATOR
Intervention: Non-IFN-α-2b group
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: IFN-α-2b therapy
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: IFN-α-2b treatment 0–2 days after symptom onset
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: IFN-α-2b treatment 3–5 days after symptom onset
Number of subjects: 1401

Group type: EXPERIMENTAL
Intervention: IFN-α-2b treatment 6–8 days after symptom onset
Number of subjects: 1401
Study: 33296971

Group type: EXPERIMENTAL
Intervention: Cladribine tablets 3.5 mg/kg
Number of subjects: 1564

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1564
Study: 35473778

Group type: EXPERIMENTAL
Intervention: Ground-based walking training (30 minutes, 2 days/week for 8 weeks, plus unsupervised walking at least 1 day/week)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 24
Study: 33091354

Group type: EXPERIMENTAL
Intervention: Blood transfusion (whole blood at a target volume of 20 mL per kg)
Number of subjects: 25893

Group type: COMPARATOR
Intervention: No blood transfusion
Number of subjects: 25893

Group type: EXPERIMENTAL
Intervention: Blood transfusion
Number of subjects: 25893
Study: 35932119

Group type: EXPERIMENTAL
Intervention: PVI guided goal‐directed fluid management (GDFM)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Conventional fluid management (CFM)
Number of subjects: 78
Study: 34402253

Group type: EXPERIMENTAL
Intervention: Dietary fiber intervention (total dietary fiber per day before meals)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (basic nutrition support)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Dietary fiber intervention
Number of subjects: 112
Study: 35882086

Group type: EXPERIMENTAL
Intervention: Cooperative practice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Competitive practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no induced cooperative or competitive conditions)
Number of subjects: 0
Study: 34377726

Group type: EXPERIMENTAL
Intervention: Care facilitation intervention (motivation and strengths-based case management)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control (referral to HCV evaluation and assistance with care appointments)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Care facilitation intervention
Number of subjects: 113

Group type: COMPARATOR
Intervention: Care facilitation intervention and Control
Number of subjects: 113
Study: 32740950

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed guar gum (PHGG) 10 g twice daily for 14 days prior and 14 days during pelvic radiation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 30
Study: 33052754

Group type: EXPERIMENTAL
Intervention: Sentinel Node (SN) biopsy
Number of subjects: 307

Group type: COMPARATOR
Intervention: Neck Dissection (ND)
Number of subjects: 307
Study: 34937821

Group type: EXPERIMENTAL
Intervention: High-dose heparin (HH) receiving an initial heparin dose of 450 u/kg
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Heparin concentration monitoring (HC) with Hepcon HMS
Number of subjects: 269

Group type: COMPARATOR
Intervention: Control group receiving a standard heparin dose of 300 u/kg
Number of subjects: 269
Study: 36239038

Group type: EXPERIMENTAL
Intervention: Zavegepant 10 mg
Number of subjects: 1673

Group type: EXPERIMENTAL
Intervention: Zavegepant 20 mg
Number of subjects: 1673

Group type: EXPERIMENTAL
Intervention: Zavegepant 5 mg
Number of subjects: 1673

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1673
Study: 34089165

Group type: EXPERIMENTAL
Intervention: Blocked training (one vowel context at a time)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interleaved training (vowel contexts were randomized)
Number of subjects: 0
Study: 32061183

Group type: EXPERIMENTAL
Intervention: 10-day moderate-intensity training protocol (60 min@50% peak power output)
Number of subjects: 20
Study: 35263502

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Combined Resistance and Aerobic Training (CT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control
Number of subjects: 42
Study: 32684537

Group type: EXPERIMENTAL
Intervention: 1-month DAPT followed by clopidogrel monotherapy
Number of subjects: 2819

Group type: COMPARATOR
Intervention: 3-month DAPT followed by aspirin monotherapy
Number of subjects: 2819
Study: 35039226

Group type: EXPERIMENTAL
Intervention: Intracoronary eptifibatide and vasodilators
Number of subjects: 413

Group type: COMPARATOR
Intervention: Thrombus aspiration alone
Number of subjects: 413
Study: 34056911

Group type: EXPERIMENTAL
Intervention: Bioresorbable-polymer sirolimus-eluting stent
Number of subjects: 2361

Group type: EXPERIMENTAL
Intervention: Durable-polymer everolimus-eluting stent
Number of subjects: 2361

Group type: EXPERIMENTAL
Intervention: Moderate/severe calcification
Number of subjects: 2361

Group type: COMPARATOR
Intervention: None/mild calcification
Number of subjects: 2361
Study: 32843081

Group type: EXPERIMENTAL
Intervention: Dutogliptin plus filgrastim (G-CSF)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 35348611

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 12609

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12609
Study: 32525525

Group type: EXPERIMENTAL
Intervention: Late Dinner (LD, 22:00)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Routine Dinner (RD, 18:00)
Number of subjects: 20
Study: 36068621

Group type: EXPERIMENTAL
Intervention: Caring Mindfulness-based Approach for Seniors (CMBAS)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Health self-management program (HSMP)
Number of subjects: 147
Study: 32275653

Group type: EXPERIMENTAL
Intervention: Insecticide-treated curtains (ITCs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control arm (non-ITC clusters)
Number of subjects: 0
Study: 35700653

Group type: EXPERIMENTAL
Intervention: Messages that described the symptoms of health effects
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Messages that included an image depicting the health effect
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Messages with a marker word or self-efficacy cue
Number of subjects: 1300
Study: 33634829

Group type: EXPERIMENTAL
Intervention: Guided exercises with joint mobilization
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Guided exercises without joint mobilization
Number of subjects: 120

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 120
Study: 33183672

Group type: EXPERIMENTAL
Intervention: F(ab')2 antivenom therapy plus local cryotherapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: F(ab')2 antivenom therapy
Number of subjects: 38
Study: 35652703

Group type: EXPERIMENTAL
Intervention: Routine treatment + escitalopram
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Routine treatment + pramipexole
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Routine treatment + transcranial magnetic stimulation (TMS)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 131
Study: 32852600

Group type: EXPERIMENTAL
Intervention: Patient-specific instrumentation (PSI)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Conventional instrumentation (CI)
Number of subjects: 131
Study: 36155390

Group type: EXPERIMENTAL
Intervention: Online antenatal education
Number of subjects: 44
Study: 34016442

Group type: EXPERIMENTAL
Intervention: Statistical tests for interaction
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Statistical analyses of randomized controlled trials
Number of subjects: 1000
Study: 32713062

Group type: EXPERIMENTAL
Intervention: LNG + EE
Number of subjects: 80

Group type: COMPARATOR
Intervention: LNG only
Number of subjects: 80
Study: 36183105

Group type: EXPERIMENTAL
Intervention: Nomogram model based on logistic regression for predicting delirium risk.
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Nomogram model based on logistic regression for predicting delirium risk (validation set).
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Independent risk factors identified: CPB duration (OR 1.004, p=0.018), postoperative serum sodium (OR 1.112, p=0.001), age (OR 1.027, p=0.011), postoperative MV (OR 1.019, p=0.001).
Number of subjects: 838

Group type: EXPERIMENTAL
Intervention: Hosmer‐Lemeshow goodness of fit test for the model.
Number of subjects: 838
Study: 34271125

Group type: EXPERIMENTAL
Intervention: Younger females (18–47 years)
Number of subjects: 23725

Group type: COMPARATOR
Intervention: Older females (≥53 years)
Number of subjects: 23725

Group type: COMPARATOR
Intervention: Older males
Number of subjects: 23725
Study: 32871701

Group type: EXPERIMENTAL
Intervention: Family‐Focused Treatment for Childhood Depression (FFT‐CD)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Individual supportive psychotherapy (IP)
Number of subjects: 134
Study: 35444121

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 32980866

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sprint Interval Exercise (SIE)
Number of subjects: 16
Study: 33726804

Group type: EXPERIMENTAL
Intervention: Enzalutamide (Xtandi®) 160 mg (4x40 mg) daily for five consecutive days
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard of care treatment for patients hospitalised with COVID‐19
Number of subjects: 600
Study: 32875505

Group type: EXPERIMENTAL
Intervention: Integrated clinical prediction rule (iCPR) system for antibiotic prescribing in ARIs
Number of subjects: 541

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 541

Group type: EXPERIMENTAL
Intervention: Integrated clinical prediction rule (iCPR) system
Number of subjects: 541
Study: 34799191

Group type: EXPERIMENTAL
Intervention: Escape room approach (EG)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Traditional-based teaching approach (CG)
Number of subjects: 248
Study: 33664429

Group type: EXPERIMENTAL
Intervention: MK-7 375 µg daily
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study: 32049562

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (30 maximum inspirations at 50% PImax, twice per day, 6 days per week)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study: 616788544

Group type: EXPERIMENTAL
Intervention: 1/4 roasted chickpea flour bread
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1/2 roasted chickpea flour bread
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: roasted chickpea flour breads
Number of subjects: 10
Study: 34486714

Group type: EXPERIMENTAL
Intervention: WhatsApp-based intervention with up to 4 physical activity promotion messages per week for 10 weeks
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: WhatsApp-based intervention
Number of subjects: 110
Study: 32898517

Group type: EXPERIMENTAL
Intervention: Battling rope (BTR) exercise
Number of subjects: 11

Group type: COMPARATOR
Intervention: Non-exercise control trial
Number of subjects: 11
Study: 35357564

Group type: EXPERIMENTAL
Intervention: Dopaminergic medication
Number of subjects: 63

Group type: COMPARATOR
Intervention: OFF medication (PD patients)
Number of subjects: 63
Study: 32717926

Group type: EXPERIMENTAL
Intervention: Ethanol consumption (35 g daily for eight weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ethanol-free control (CTL) group
Number of subjects: 0
Study: 33687323

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for insomnia (CBTi) and manual standardized stress acupuncture (MSSA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive-behavioral therapy for insomnia (CBTi) only
Number of subjects: 0
Study: 35398450

Group type: EXPERIMENTAL
Intervention: Self-etch (SEE)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Selective enamel etching + self-etch (SET)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Etch-and-rinse with dry dentin (ERDry)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Etch-and-rinse with wet dentin (ERWet)
Number of subjects: 50
Study: 33714975

Group type: EXPERIMENTAL
Intervention: Short-term application of 6-thioguanine (6-TG)
Number of subjects: 3983
Study: 35767586

Group type: EXPERIMENTAL
Intervention: Non-selective screening strategy
Number of subjects: 326

Group type: COMPARATOR
Intervention: Selective screening strategy
Number of subjects: 326
Study: 33183574

Group type: EXPERIMENTAL
Intervention: Active tDCS (transcranial direct current stimulation) along with a hypocaloric diet (HD)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham tDCS (placebo) along with a hypocaloric diet (HD)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Active tDCS (transcranial direct current stimulation)
Number of subjects: 28
Study: 34390923

Group type: EXPERIMENTAL
Intervention: Concentric mSIT cycling (CON)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Eccentric mSIT cycling (ECC)
Number of subjects: 25
Study: 32471328

Group type: EXPERIMENTAL
Intervention: DRSP/20EE
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: DRSP/30EE
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control (not using oral contraceptives)
Number of subjects: 78
Study: 36216658

Group type: EXPERIMENTAL
Intervention: Niraparib 300 or 200 mg daily plus best supportive care (BSC)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Best supportive care (BSC) alone
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Niraparib plus BSC
Number of subjects: 58

Group type: COMPARATOR
Intervention: BSC alone
Number of subjects: 58
Study: 32122822

Group type: EXPERIMENTAL
Intervention: Thermodilution-derived temperature recovery time (TRT) measured immediately post PCI.
Number of subjects: 271
Study: 32359738

Group type: EXPERIMENTAL
Intervention: Even dietary advice strategy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Peak dietary advice strategy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 35902157

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study: 35504836

Group type: EXPERIMENTAL
Intervention: Behavioral intervention that increased vegetable intake
Number of subjects: 387
Study: 34096641

Group type: EXPERIMENTAL
Intervention: Parent-led cognitive behavioural therapy (From Timid to Tiger), 8 sessions
Number of subjects: 71

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 71
Study: 36256505

Group type: EXPERIMENTAL
Intervention: CC-90001 (10–720 mg single dose or 30–480 mg once daily for 7–18 days)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: CC-90001
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study: 33971928

Group type: EXPERIMENTAL
Intervention: Music exercise therapy
Number of subjects: 81

Group type: COMPARATOR
Intervention: Routine rehabilitation therapies
Number of subjects: 81

Group type: COMPARATOR
Intervention: Music exercise without music
Number of subjects: 81
Study: 35962638

Group type: EXPERIMENTAL
Intervention: 3 µg/kg of intranasal desmopressin acetate
Number of subjects: 120

Group type: COMPARATOR
Intervention: 1 mL/kg of intranasal sodium chloride 0.65% (placebo)
Number of subjects: 120
Study: 33065164

Group type: EXPERIMENTAL
Intervention: Prognostic model for predicting deterioration in health-related quality of life (dHRQoL) based on 12/87 selected variables related to chronic conditions, medication, functional status, well-being, and HRQoL.
Number of subjects: 3582
Study: 32817632

Group type: EXPERIMENTAL
Intervention: 12% N,N‐diethylbenzamide w/w cream distributed by village health volunteers (VHVs)
Number of subjects: 32194
Study: 34489292

Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes (PROs) as primary outcomes
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes (PROs) as secondary outcomes
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Short-Form 36 (SF-36) as the most used PRO
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Statistical methods for analysis of PROs
Number of subjects: 303
Study: 37340514

Group type: EXPERIMENTAL
Intervention: Intralesional autologous PRP plus classic topical treatment
Number of subjects: 94

Group type: COMPARATOR
Intervention: Topical compounds only
Number of subjects: 94
Study: 32723508

Group type: EXPERIMENTAL
Intervention: Low Fat High Carbohydrate Control (LFHCC) diet
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Pathways analysis
Number of subjects: 462
Study: 32668588

Group type: EXPERIMENTAL
Intervention: HP‐MCHO (high-protein/moderate carbohydrate) meal
Number of subjects: 14

Group type: COMPARATOR
Intervention: LP‐HCHO (low-protein/high-carbohydrate) meal
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Standard breakfast after night meal
Number of subjects: 14
Study: 33511686

Group type: EXPERIMENTAL
Intervention: Tocilizumab (single infusion)
Number of subjects: 46
Study: 32546253

Group type: EXPERIMENTAL
Intervention: Targeted recruitment methods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-targeted recruitment methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both recruitment methods
Number of subjects: 0
Study: 35751042

Group type: EXPERIMENTAL
Intervention: LASIK Xtra
Number of subjects: 25

Group type: COMPARATOR
Intervention: convLASIK
Number of subjects: 25
Study: 36117310

Group type: EXPERIMENTAL
Intervention: Systemic inflammation (SI) with LPS injections (1 ng/kg and 0.5 ng/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Healthy conditions (HC)
Number of subjects: 8
Study: 34273115

Group type: EXPERIMENTAL
Intervention: BUYOI-AI
Number of subjects: 497

Group type: COMPARATOR
Intervention: Control
Number of subjects: 497
Study: 33463774

Group type: EXPERIMENTAL
Intervention: Splinted crowns (n = 11)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-splinted crowns (n = 13)
Number of subjects: 20
Study: 33453708

Group type: EXPERIMENTAL
Intervention: Robot-assisted percutaneous vertebroplasty (PVP) under local anaesthesia
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 30
Study: 34860732

Group type: EXPERIMENTAL
Intervention: PwCOVID
Number of subjects: 75

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 75
Study: 33534818

Group type: EXPERIMENTAL
Intervention: Combined protocol using an optimised MUAC-based dose of ready-to-use therapeutic food (RUTF)
Number of subjects: 850

Group type: COMPARATOR
Intervention: Standard care using weight-based RUTF rations for SAM and ready-to-use supplementary food (RUSF) for MAM
Number of subjects: 850

Group type: EXPERIMENTAL
Intervention: Combined protocol
Number of subjects: 850

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 850
Study: 35522238

Group type: EXPERIMENTAL
Intervention: User-centered reports
Number of subjects: 456

Group type: COMPARATOR
Intervention: Control reports from a United Kingdom national genomic laboratory hub
Number of subjects: 456
Study: 33422245

Group type: EXPERIMENTAL
Intervention: Bio‐Manguinhos‐Fiocruz standard dose
Number of subjects: 960

Group type: COMPARATOR
Intervention: Bio‐Manguinhos‐Fiocruz fractional dose
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Chumakov Institute of Poliomyelitis and Viral Encephalitides standard dose
Number of subjects: 960

Group type: COMPARATOR
Intervention: Chumakov Institute of Poliomyelitis and Viral Encephalitides fractional dose
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Institut Pasteur Dakar standard dose
Number of subjects: 960

Group type: COMPARATOR
Intervention: Institut Pasteur Dakar fractional dose
Number of subjects: 960

Group type: EXPERIMENTAL
Intervention: Sanofi Pasteur standard dose
Number of subjects: 960

Group type: COMPARATOR
Intervention: Sanofi Pasteur fractional dose
Number of subjects: 960
Study: 34059348

Group type: EXPERIMENTAL
Intervention: Intervention (3 standardized CBT‐based sessions in the 6–12 weeks post‐chemotherapy)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control (standard of care)
Number of subjects: 107
Study: 32321161

Group type: EXPERIMENTAL
Intervention: High Breakfast (HBR) group, n=12, protein intake at breakfast: 0.33 g/kg BW, lunch: 0.46 g/kg BW, dinner: 0.48 g/kg BW, total daily protein intake: 1.30 g/kg BW/d
Number of subjects: 26

Group type: COMPARATOR
Intervention: Low Breakfast (LBR) group, n=14, protein intake at breakfast: 0.12 g/kg BW, lunch: 0.45 g/kg BW, dinner: 0.83 g/kg BW, total daily protein intake: 1.30 g/kg BW/d
Number of subjects: 26
Study: 33246497

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroid injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline injection (placebo)
Number of subjects: 0
Study: 35232509

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Waiting List (WL)
Number of subjects: 80
Study: 34348947

Group type: EXPERIMENTAL
Intervention: Prognostic model developed using individual participant data from four cluster-randomised trials.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internal-external cross-validation (IECV) of the prognostic model.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Predictor effect heterogeneity and differing baseline risk.
Number of subjects: 0
Study: 616063448

Group type: EXPERIMENTAL
Intervention: Ipsilateral breast tumor recurrence (IBTR)
Number of subjects: 1975

Group type: EXPERIMENTAL
Intervention: Primary tumor characteristics (T size, nodal status)
Number of subjects: 1975

Group type: EXPERIMENTAL
Intervention: ER-negative cohort
Number of subjects: 1975

Group type: COMPARATOR
Intervention: IBTR occurrence
Number of subjects: 1975